Process View
The chemical reactions and pathways resulting in the formation of major histocompatibility protein class II.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "mhc class ii biosynthetic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.998 | Human | |
| IL8 | interleukin 8 | 0.998 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.997 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.980 | Human | |
| IL4R | interleukin 4 receptor | 0.900 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.880 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.832 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.646 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.634 | ||
| PF4 | platelet factor 4 | 0.610 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.597 | Human | |
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.551 | Human | |
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.470 | ||
| IL1B | interleukin 1, beta | 0.420 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.409 | ||
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.364 | Human | |
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.348 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.324 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.245 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.198 | Human | |
| UBD | ubiquitin D | 0.193 | ||
| FOXO3 | forkhead box O3 | 0.165 | ||
| AZU1 | azurocidin 1 | 0.158 | ||
| PF4V1 | platelet factor 4 variant 1 | 0.148 | Human | |
| S100A12 | S100 calcium binding protein A12 | 0.105 | ||
| MPO | myeloperoxidase | 0.101 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.097 | ||
| EP300 | E1A binding protein p300 | 0.091 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.089 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.087 | ||
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.087 | ||
| IFNG | interferon, gamma | 0.086 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.085 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.081 | ||
| PRTN3 | proteinase 3 | 0.072 | Human | |
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.071 | Human | |
| IRS2 | insulin receptor substrate 2 | 0.068 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.067 | ||
| SELE | selectin E | 0.066 | ||
| IFI44 | interferon-induced protein 44 | 0.062 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.060 | ||
| HBA2 | hemoglobin, alpha 2 | 0.057 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.057 | ||
| OASL | 2'-5'-oligoadenylate synthetase-like | 0.055 | ||
| DNAJB9 | DnaJ (Hsp40) homolog, subfamily B, member 9 | 0.055 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.053 | ||
| ELANE | elastase, neutrophil expressed | 0.052 | Human | |
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.051 | ||
| APOL1 | apolipoprotein L, 1 | 0.050 | ||
| RSAD2 | radical S-adenosyl methionine domain containing 2 | 0.044 | ||
| TLR2 | toll-like receptor 2 | 0.041 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.039 | ||
| LCN2 | lipocalin 2 | 0.038 | ||
| NFE2 | nuclear factor (erythroid-derived 2), 45kDa | 0.037 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.035 | ||
| GFI1 | growth factor independent 1 transcription repressor | 0.035 | ||
| MOBKL2B | MOB1, Mps One Binder kinase activator-like 2B (yeast) | 0.032 | ||
| EFNA1 | ephrin-A1 | 0.032 | ||
| HBD | hemoglobin, delta | 0.031 | ||
| TFEC | transcription factor EC | 0.031 | ||
| CSNK2A2 | casein kinase 2, alpha prime polypeptide | 0.030 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.030 | ||
| ALB | albumin | 0.029 | ||
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 0.029 | ||
| RPS27 | ribosomal protein S27 | 0.028 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.028 | ||
| BCL2A1 | BCL2-related protein A1 | 0.027 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.026 | ||
| IFI44L | interferon-induced protein 44-like | 0.025 | ||
| DEFA4 | defensin, alpha 4, corticostatin | 0.025 | ||
| RNASE3 | ribonuclease, RNase A family, 3 | 0.024 | ||
| MS4A3 | membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) | 0.023 | ||
| CXCR2 | chemokine (C-X-C motif) receptor 2 | 0.023 | ||
| OAS2 | 2'-5'-oligoadenylate synthetase 2, 69/71kDa | 0.023 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.023 | ||
| IL10 | interleukin 10 | 0.023 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.022 | Human | |
| RGS1 | regulator of G-protein signaling 1 | 0.022 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.022 | ||
| CTSG | cathepsin G | 0.021 | ||
| MMP8 | matrix metallopeptidase 8 (neutrophil collagenase) | 0.021 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.021 | ||
| ALAS2 | aminolevulinate, delta-, synthase 2 | 0.021 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.021 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.020 | ||
| CLEC4G | C-type lectin domain family 4, member G | 0.019 | ||
| POU2F2 | POU class 2 homeobox 2 | 0.019 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.019 | ||
| IFI27 | interferon, alpha-inducible protein 27 | 0.019 | ||
| GP5 | glycoprotein V (platelet) | 0.019 | ||
| NRGN | neurogranin (protein kinase C substrate, RC3) | 0.018 | ||
| RAD52 | RAD52 homolog (S. cerevisiae) | 0.018 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.018 | ||
| BPI | bactericidal/permeability-increasing protein | 0.018 | ||
| RRP8 | ribosomal RNA processing 8, methyltransferase, homolog (yeast) | 0.018 | ||
| SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0.017 | ||
| APOL6 | apolipoprotein L, 6 | 0.017 | ||
| PTX3 | pentraxin 3, long | 0.017 | ||
| IFIT2 | interferon-induced protein with tetratricopeptide repeats 2 | 0.017 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.017 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.017 | ||
| INHBA | inhibin, beta A | 0.017 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.017 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.016 | ||
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.016 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.016 | ||
| HBB | hemoglobin, beta | 0.016 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.015 | ||
| PLEK | pleckstrin | 0.015 | ||
| CD83 | CD83 molecule | 0.015 | ||
| AIM2 | absent in melanoma 2 | 0.014 | ||
| VNN1 | vanin 1 | 0.014 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.014 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.014 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.014 | ||
| GBP4 | guanylate binding protein 4 | 0.014 | ||
| IRAK3 | interleukin-1 receptor-associated kinase 3 | 0.014 | ||
| EREG | epiregulin | 0.014 | ||
| TNF | tumor necrosis factor | 0.014 | ||
| KYNU | kynureninase | 0.013 | ||
| RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.013 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.013 | ||
| CLC | Charcot-Leyden crystal protein | 0.013 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.013 | ||
| TNFSF4 | tumor necrosis factor (ligand) superfamily, member 4 | 0.013 | ||
| IRAK4 | interleukin-1 receptor-associated kinase 4 | 0.013 | ||
| BMP2 | bone morphogenetic protein 2 | 0.012 | ||
| HOXA10 | homeobox A10 | 0.012 | ||
| IL18R1 | interleukin 18 receptor 1 | 0.012 | ||
| VPREB1 | pre-B lymphocyte 1 | 0.012 | ||
| PLA1A | phospholipase A1 member A | 0.012 | ||
| IL13RA2 | interleukin 13 receptor, alpha 2 | 0.012 | ||
| RETN | resistin | 0.012 | ||
| SPOP | speckle-type POZ protein | 0.012 | ||
| IL7 | interleukin 7 | 0.012 | ||
| IL7R | interleukin 7 receptor | 0.011 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.011 | ||
| S100P | S100 calcium binding protein P | 0.011 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.011 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.011 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.010 | ||
| FPR3 | formyl peptide receptor 3 | 0.010 | ||
| IL1A | interleukin 1, alpha | 0.010 | ||
| IL11 | interleukin 11 | 0.010 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.010 | ||
| HP | haptoglobin | 0.010 | ||
| FOXO1 | forkhead box O1 | 0.010 |